These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay. Lippi G; Salvagno GL; Gelati M; Pucci M; Demonte D; Faggian D; Plebani M Diagnostics (Basel); 2020 Feb; 10(3):. PubMed ID: 32111028 [TBL] [Abstract][Full Text] [Related]
24. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay. Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802 [TBL] [Abstract][Full Text] [Related]
25. Method for the selective measurement of amino-terminal variants of procalcitonin. Struck J; Strebelow M; Tietz S; Alonso C; Morgenthaler NG; van der Hoeven JG; Pickkers P; Bergmann A Clin Chem; 2009 Sep; 55(9):1672-9. PubMed ID: 19574469 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum. Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213 [TBL] [Abstract][Full Text] [Related]
27. Immunoluminometric detection of human procalcitonin. Köszegi T J Biochem Biophys Methods; 2002; 53(1-3):157-64. PubMed ID: 12406598 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays. Walker C; Shuster A; Weber C; Gebhardt K; Scheidegger M; Swartzwelder J; Williams J; Li J Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of procalcitonin with liquid-phase binding assay in hematological malignancy. Koya J; Nannya Y; Kurokawa M Clin Chim Acta; 2012 Oct; 413(19-20):1633-6. PubMed ID: 22579768 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of measurement method of a bacterial sepsis marker, procalcitonin]. Adachi S; Nakao K Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2010; 21(2):107-9. PubMed ID: 22096868 [TBL] [Abstract][Full Text] [Related]
31. Total internal reflection (TIRF)-based quantification of procalcitonin for sepsis diagnosis--a point-of-care testing application. Rascher D; Geerlof A; Kremmer E; Krämer P; Michael S; Hartmann A; Rieger M Biosens Bioelectron; 2014 Sep; 59():251-8. PubMed ID: 24732603 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Procalcitonin Assays on KRYPTOR and LIAISON Dipalo M; Gnocchi C; Avanzini P; Musa R; Di Pietro M; Aloe R Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31398868 [TBL] [Abstract][Full Text] [Related]
33. Magnetic-particle-based, ultrasensitive chemiluminescence enzyme immunoassay for free prostate-specific antigen. Liu R; Wang C; Jiang Q; Zhang W; Yue Z; Liu G Anal Chim Acta; 2013 Nov; 801():91-6. PubMed ID: 24139579 [TBL] [Abstract][Full Text] [Related]
34. The use of a personal glucose meter for detecting procalcitonin through glucose encapsulated within liposomes. Alshawawreh F; Lisi F; Ariotti N; Bakthavathsalam P; Benedetti T; Tilley RD; Gooding JJ Analyst; 2019 Nov; 144(21):6225-6230. PubMed ID: 31555776 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer]. El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524 [TBL] [Abstract][Full Text] [Related]
36. A sensitive and rapid chemiluminescence immunoassay for point-of-care testing (POCT) of copeptin in serum based on high-affinity monoclonal antibodies via cytokine-assisted immunization. Wang Y; Dzakah EE; Kang Y; Cai Y; Wu P; Tang B; Li R; He X Int J Nanomedicine; 2019; 14():4293-4307. PubMed ID: 31354261 [No Abstract] [Full Text] [Related]
37. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Morgenthaler NG; Struck J; Fischer-Schulz C; Seidel-Mueller E; Beier W; Bergmann A Clin Lab; 2002; 48(5-6):263-70. PubMed ID: 12071576 [TBL] [Abstract][Full Text] [Related]
38. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis. Hirose O; Itabashi M; Takei T; Nitta K Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618 [TBL] [Abstract][Full Text] [Related]
39. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor. Ceriotti F; Marino I; Motta A; Carobene A Clin Chem Lab Med; 2017 Nov; 56(1):162-169. PubMed ID: 28809746 [TBL] [Abstract][Full Text] [Related]
40. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]